Papers in Cancer Drug Resistance
Page 2 · newest first
- Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategiesCancer Drug Resistance · 2025
- Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistanceCancer Drug Resistance · 2025
- Cryptotanshinone differentially induces cell death in ATP6V0D1-deficient pancreatic cancer cellsCancer Drug Resistance · 2025
- New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancerCancer Drug Resistance · 2025
- ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancerCancer Drug Resistance · 2025
- Resistance signatures manifested in early drug response across cancer types and speciesCancer Drug Resistance · 2025
- IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancerCancer Drug Resistance · 2025
- Effects of FAP⁺ cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4⁺ T cell polarization in gastric cancerCancer Drug Resistance · 2025
- Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expressionCancer Drug Resistance · 2025
- Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectivesCancer Drug Resistance · 2025
- CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axisCancer Drug Resistance · 2025
- The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapyCancer Drug Resistance · 2025
- Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCCCancer Drug Resistance · 2025
- Modeling methods of different tumor organoids and their application in tumor drug resistance researchCancer Drug Resistance · 2025
- Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancerCancer Drug Resistance · 2025
- MicroRNA-mediated autophagy regulation in thyroid cancer drug resistanceCancer Drug Resistance · 2025
- Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategiesCancer Drug Resistance · 2025
- Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumorsCancer Drug Resistance · 2025
- Acquired resistance to molecularly targeted therapies for cancerCancer Drug Resistance · 2025
- PER2 expression and cellular localization play a critical role in tumor aggressiveness and drug resistance in an in vitro model of hepatocellular carcinomaCancer Drug Resistance · 2025
- ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLCCancer Drug Resistance · 2025
- Advances in the application of patient-derived xenograft models in acute leukemia resistanceCancer Drug Resistance · 2025
- Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancerCancer Drug Resistance · 2025
- Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformationCancer Drug Resistance · 2025
- Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemnessCancer Drug Resistance · 2025
- The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistanceCancer Drug Resistance · 2025
- Mechanisms of resistance to NAMPT inhibitors in cancerCancer Drug Resistance · 2025
- Circular RNAs modulate cancer drug resistance: advances and challengesCancer Drug Resistance · 2025
- Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AMLCancer Drug Resistance · 2025
- Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosisCancer Drug Resistance · 2025
- Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathwaysCancer Drug Resistance · 2025
- Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer typesCancer Drug Resistance · 2025
- Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencingCancer Drug Resistance · 2025
- Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinomaCancer Drug Resistance · 2025
- The epigenetic mechanisms involved in the treatment resistance of glioblastomaCancer Drug Resistance · 2025
- Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approachesCancer Drug Resistance · 2025
- Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapyCancer Drug Resistance · 2025
- Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistanceCancer Drug Resistance · 2025
- Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancersCancer Drug Resistance · 2025
- Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progressionCancer Drug Resistance · 2025
- Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancersCancer Drug Resistance · 2025
- Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinomaCancer Drug Resistance · 2025
- Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironmentCancer Drug Resistance · 2025
- Ferroptosis-related signaling pathways in cancer drug resistanceCancer Drug Resistance · 2025
- Mechanisms of immunotherapy resistance in small cell lung cancerCancer Drug Resistance · 2024
- Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumorsCancer Drug Resistance · 2024
- Ovarian tumor microenvironment contributes to tumor progression and chemoresistanceCancer Drug Resistance · 2024
- Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancerCancer Drug Resistance · 2024
- Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatmentCancer Drug Resistance · 2024
- The emerging role of GLP-1 receptor agonists in treating or preventing cancerCancer Drug Resistance · 2024